Dermatitis And Other Skin Articles & Analysis: Older
8 news found
People with sunburned, burnt or dry skin, it is best to moisturise and repair, and then operate after the skin returns to normal. ...
(NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that a discussion on the RECELL System will be held during the Symposium for Cosmetic Advances & Laser Education (SCALE) multidisciplinary dermatology ...
(NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that an abstract highlighting the clinical trial protocol utilizing the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat vitiligo will be ...
Low dose arm of the study met the co-primary endpoints of percent change in Eczema Area and Severity Index (EASI) score from baseline, and incidence of treatment-emergent adverse events, through week 16 First trial to assess the effects of blocking OX40-Ligand, a key immune system regulator, in patients with moderate-to-severe atopic dermatitis Data support amlitelimab as a potential ...
Most recently, LEA was published with other novel molecules in a Patent Cooperation Treaty (PCT) Patent under Publication No. WO/2021/09735 “Functionalized 1,3-Benzene Diols and Their Method of Use for the Treatment of Radiation Dermatitis and Other Skin Disorders.” LEA™, the Company’s novel small ...
WO/2021/097351 “Functionalized 1,3-Benzene Diols and Their Method of Use for the Treatment of Radiation Dermatitis and Other Skin Disorders.” One of the compounds disclosed as part of this PCT Patent is the Company’s proprietary ingredient LEA™. ...
Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbiome, today announced a collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to conduct a clinical study in children at risk for developing atopic dermatitis. The study will assess the effects of ...
Because glutaraldehyde is a liquid at room temperature it can affect the health of users as a vapour and through physical contact with the skin. Glutaraldehyde mainly affects the first body tissue it touches causing irritation of the eyes, nose, throat, lungs or skin. ...